TRN-008

N/A

Report date: 2022/01/05 15:24:33

NME

Base Information

Drug NameTRN-008

Drug Alias NameTRN-008

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProto-oncogene tyrosine-protein kinase ROS inhibitorsHepatocyte growth factor receptor inhibitorsAnaplastic lymphoma kinase inhibitors

TargetsProto-oncogene tyrosine-protein kinase ROSHepatocyte growth factor receptorAnaplastic lymphoma kinase

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesTYK Medicines Inc

China Registration ClassN/A

Develop Information

Active CompaniesTYK Medicines Inc

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A